Moftakhar, Leila
Jafari, Fatemeh
Ghoddusi Johari, Masoumeh
Rezaeianzadeh, Ramin
Hosseini, Seyed Vahid
Rezaianzadeh, Abbas
Article History
Received: 18 September 2022
Accepted: 6 December 2022
First Online: 19 December 2022
Declarations
:
: PERSIAN Cohort Study is being performed in 18 geographical regions of Iran. PERSIAN Cohort Study was approved by the ethics committees of the Ministry of Health and Medical Education Shiraz is one of the regions. The Kharameh cohort study with approval code 7421 is part of the large Persian study. This study is in agreement with the Helsinki declaration and Iranian national guidelines for ethics in research, and informed consent was taken from all individuals who wished to participate in the study. Also, informed consent is obtained from one of the family members, the illiterate participants.
: Not applicable.
: The authors declare that they have no competing interests.